PLG Bridge Implantation in Chronic SCI Promotes Axonal Elongation and Myelination by Smith, Dominique R et al.
UC Irvine
UC Irvine Previously Published Works
Title
PLG Bridge Implantation in Chronic SCI Promotes Axonal Elongation and Myelination
Permalink
https://escholarship.org/uc/item/2d02z28g
Journal
ACS Biomaterials Science & Engineering, 5(12)
ISSN
2373-9878
Authors
Smith, Dominique R
Dumont, Courtney M
Ciciriello, Andrew J
et al.
Publication Date
2019-12-09
DOI
10.1021/acsbiomaterials.9b01012
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Title: Polycistronic  delivery  of  IL-10  and  NT-3  promotes  oligodendrocyte
myelination and functional recovery
Authors: Dominique  R.  Smith1,  Courtney  M.  Dumont2,3,  Jonghyuck  Park1,
Andrew  J.  Ciciriello1,2,3,  Amina  Guo1,  Ravindra  Tatineni1,  Brian  J.
Cummings4,5,6,7, Aileen J. Anderson4,5,6,7, Lonnie D. Shea1,8*
1Department of Biomedical Engineering, University of Michigan, Ann Arbor,
MI, USA,
2Department of Biomedical Engineering, University of Miami, Coral Gables,
FL, USA
3Biomedical  Nanotechnology  Institute  at  University  of  Miami  (BioNIUM),
University of Miami, Miami, FL, USA, 
4Institute  for  Memory  Impairments  and  Neurological  Disorders  (iMIND),
University of California, Irvine, CA, USA
5Sue  and  Bill  Gross  Stem  Cell  Research  Center,  University  of  California,
Irvine, CA, USA
6Department of Anatomy and Neurobiology, University of California, Irvine,
CA, USA
7Department of Physical Medicine and Rehabilitation, University of California,
Irvine, CA, USA
8Department of Chemical Engineering, University of Michigan, Ann Arbor, MI,
USA
Abstract
One million estimated cases of spinal cord injury (SCI) have been reported
in the United States and repairing an injury has constituted a difficult clinical
challenge. The complex, dynamic, inhibitory microenvironment post injury,
which  is  characterized  by  pro-inflammatory  signaling  from  invading
leukocytes and lack of  sufficient factors that promote axonal survival and
elongation,  limits  regeneration.  Herein,  we  investigated  the  delivery  of
polycistronic  vectors,  which  have the  potential  to  co-express  factors  that
target distinct barriers to regeneration, from a multiple channel PLG bridge
to enhance spinal cord regeneration. In the present study, we investigated
polycistronic delivery of IL-10, that targets pro-inflammatory signaling, and
NT-3 that targets axonal survival and elongation. A significant increase was
observed  in  the  density  of  regenerative  macrophages  for  IL-10+NT-3
condition  relative  to  conditions  without  IL-10.  Furthermore,  combined
delivery of IL-10+NT-3 produced a significant increase of axonal density and
notably  myelinated  axons  compared  to  all  other  conditions.  A  significant
increase in functional recovery was observed for IL-10+NT-3 delivery at 12
wpi  that  was  positively  correlated  to  oligodendrocyte  myelinated  axon
density, suggesting oligodendrocyte-mediated myelination as an important
target to improve functional recovery. These results further support the use
of  multiple  channel  PLG  bridges  as  a  growth  supportive  substrate  and
platform to deliver bioactive agents to modulate the SCI microenvironment
and promote regeneration and functional recovery. 
Keywords:  spinal cord injury, biomaterial, gene therapy, axon elongation,
axon myelination
Impact Statement
Spinal cord injury (SCI) results in a complex microenvironment that contains
multiple barriers to regeneration and functional recovery. Multiple factors are
necessary  to  address  these  barriers  to  regeneration,  and  polycistronic
lentiviral  gene  therapy  represent  a  strategy  to  locally  express  multiple
factors  simultaneously.  A bi-cistronic  vector  encoding IL-10 and NT-3 was
delivered from a PLG bridge, which provides structural support that guides
regeneration,  resulting  in  increased  axonal  growth,  myelination,  and
subsequent functional recovery. These results demonstrate the opportunity
of targeting multiple barriers to SCI regeneration for synergistic effect. 
Introduction
Approximately 17,000  estimated new cases of SCI occur in the United
States each year and repairing an injury to the spinal cord has constituted
one of the most difficult clinical challenges1. The CNS does not regenerate
largely  due  to  an  inhibitory  microenvironment  post  injury.  Biomaterial
bridges are among strategies to overcome some aspects of the inhibition 2-8.
We  have  developed  multi-channel  PLG  bridges  with  an  architecture  for
cellular  infiltration  and  axon  elongation.  While  the  bridge  provides  some
support,  they  alone  are  insufficient  due  to  complex,  dynamic  inhibitory
microenvironment.  
The  inhibitory  environment  consists  of  multiple  barriers  to  nerve
regeneration,  most  notably  pro-inflammatory  signaling  from  invading
immune cells and lack of sufficient factors that promote axonal survival and
elongation9.  Analysis  of  this  environment  has  led to  the discovery  of  the
cytokine/neurotrophin  axis  in  axon  growth.  Cytokines  (IL-10,  IL-4,  IL-6)
released  by  invading  macrophages  can  influence  the  expression  of
neurotrophins (NT-3, NT-4, NGF) and their receptors10. Macrophages invade
the lesion and contribute to both injury and repair 11. Macrophages exist on a
spectrum  of  activation  states  ranging  from  pro-inflammatory  to  pro-
regenerative  12,  13.  Pro-regenerative  macrophages  present  enhanced
phagocytosis capabilities  14,  15 and can promote tissue regeneration  11. The
pro-inflammatory/pro-regenerative ratio  can expedite  or  drastically  reduce
axonal  growth  into  the  lesion  site16.  Combinations  of  interleukins  and
neurotrophins have been shown to promote or inhibit neurite extension in
vitro, though the ability to locally deliver combinations of factors has limited
the in vivo translation 10, 17. 
Traditional  strategies  for  localized  delivery  of  factors  to  augment  the
microenvironment  involve  osmotic  pumps  which  can  clog  and  require
surgery for removal or direct injection of factors that are rapidly cleared and
lead to off-target effects18-20. In addition to providing structural support for
regenerating  tissue,  our  bridges  are  also  capable  of  long-term,  localized
transgene expression of lentivirus. Previously, single viral vectors have been
delivered with positive results, but the multiple barriers to regeneration must
be addressed simultaneously to create holistic treatments for SCI. Delivering
multiple lentiviruses may result in inactivation or increased immunogenicity.
These  limitations  suggest  we  need  an  effective  way  to  delivery  multiple
factors without increased concentrations of lentivirus. 
In  the  present  study,  we  investigated  polycistronic  vectors  for  co-
expression of NT-3 and IL-10 using PLG bridges after acute SCI. Polycistronic
vectors negate the limitations  of  single lentiviral  vectors  by encoding co-
expression  of  multiple  genes  by  adding  “self-cleaving”  2A  peptide  sites
between genes. 2A peptides can lead to high levels of downstream protein
expression compared to other strategies for multi gene co-expression and
are small  enough to not  negatively  interfere  with the function of  the co-
expressed genes21.  IL-10 can alter the phenotype of invading macrophages
towards  a  pro-regenerative  phenotype  and  lead  to  improved  spinal  cord
regeneration  22,  23, while NT-3 expression can promote neuron survival and
axonal elongation19. Herein,  we investigated the potential for co-expression
to  influence macrophage  phenotypes,  axonal  elongation  and myelination,
and  source  of  the  myelination  at  12  weeks  post  injury,  with  subsequent
studies assessing the functional benefits of co-delivery. This research builds
upon  the  success  of  the  multiple  channel  poly(lactide-co-glycolide)  (PLG)
bridges by delivering multiple gene factors that target distinct barriers  to
regeneration to elucidate synergistic relationships.
Methods
Virus Production and validation 
Lentivirus was produced as previously described2. Briefly, HEK-293FT cells
(80-90% confluent, American Type Culture Collection (ATCC), Manassas, VA,
USA) were transfected with third generation lentiviral packaging vectors and
pLenti-CMV-Luciferase,  pLenti-CMV-hNT3, pLenti-CMV-hIL10,  or  pLenti-CMV-
hIL10/NT3.  Plasmids  were  incubated  in  OptiMEM  (Life  Technologies,
Carlsbad,  CA, USA) with Lipofectamine 2000 (Life  Technologies)  and then
added to cells. After 48 hours supernatant was centrifuged to remove and
then incubated with PEG-It (System Biosciences, Palo Alto, CA, USA). Virus
was centrifuged, supernatant was removed, and the pellet was re-suspended
in sterile phosphate buffered saline (PBS; Life Technologies). Virus aliquots
were frozen at -80°C until use. Viral titers used throughout the study were
2E9 IU/mL as determined by the Lentivirus qPCR Titer Kit (Applied Biological
Materials, Richmond, BC, Canada). 
Fabrication of multi-channel bridges
Bridges were fabricated using a sacrificial template variation24 of the gas
foaming/particulate leaching technique, as previously described19, 25. Briefly,
PLG (75:25  lactide:glycolide;  i.v.  0.70  -  .90 dL/g;  Lactel,  Birmingham,  AL,
USA) was dissolved in dichloromethane (6% w/w) and emulsified in 1% poly
(vinyl-alcohol) using a homogenizer (PolyTron 3100; Kinematica AG, Littau,
Switzerland) to create microspheres (z-average diameter ~1µm). D-sucrose
(Sigma Aldrich), D-glucose (Sigma Aldrich), and dextran MW 100,000 (Sigma
Aldrich) were mixed at a ratio of 5.3:2.5:1 respectively by mass. The mixture
was caramelized, cooled, and drawn from solution with a Pasteur pipette to
make sugar fibers. Fibers were drawn to 150 – 250 µm, coated with a 1:1
mixture of PLG microspheres and salt (63-106 μm) and pressed into a salt-
lined aluminum mold. The sugar strands were used to create 9 channels and
the salt  created a porous structure.  The materials were then equilibrated
with CO2 gas at 800 psi in a custom-made pressure vessel. Bridges were cut
into 1.15 mm sections and leached to remove salt porogen. The bridges were
stored in a desiccator until use. 
Virus loading into bridges
Bridges were disinfected in 70% ethanol and washed with sterile water.
Bridges were then saturated with 2 μL of virus. After 2 minutes of incubation,
sterile filter paper was touched to the surface of the bridge to remove excess
moisture. This process was repeated with another 2 μL of virus. The bridges
were stored on ice until  use. Bridges were used within 3 hours of coating
with  lentivirus  to  preserve  viral  activity.  Lentivirus  loading  conditions
included NT-3, IL-10, and IL-10+NT-3.
Mouse spinal cord hemisection
All  animal  procedures  were  approved  and  in  accordance  with  the
Institutional Animal Care and Use Committee at the University of Michigan. A
hemisection model of SCI was performed on female C57BL/6 mice (6-8 weeks
old;  Jackson  Laboratories,  Bar  Harbor,  ME,  USA,  N=48)  as  previously
described5.  After  administration  of  bupivacaine  (.8  ml/kg),  a  laminectomy
was performed at C5 to allow for a 1.15 mm lateral hemisection on the left
side of the spinal cord for bridge implantation. The injury site was covered
using Gelfoam (Pfizer, New York, NY, USA) followed by suturing together of
the  muscle  and  stapling  of  skin.  Postoperative  care  consisted  of
administration of enrofloxacin (2.5 mg/kg; daily for 2 weeks), buprenorphine
(0.1 mg/kg; twice daily for 3 days), and Lactated Ringer’s solution (5 mL/100
g;  daily  for  5  days).  Bladders  were  expressed  twice  daily  until  function
recovered. No mice were loss using this injury model.
Western blot
Spinal  cord tissues were collected at 2 wpi and lysed with RIPA buffer
(Thermo  Fisher,  Waltham,  MA,  USA)  supplemented  with  Halt  Protease
Inhibitor  Cocktail  (Thermo  Fisher).  The  lysate  was  then  sonicated  and
centrifuged.  The supernatant  was  added with  2x  Lammeli  Buffer  (Biorad,
Hercules, CA, USA) and boiled for 5 minutes at 95°C. Samples were ran on a
4-15% gradient SDS-PAGE gel (Biorad) and proteins were transferred to .45
um  nitrocellulose  membranes.  After  blocking  with  BLOK  Casein  (G-
Biosciences,  St.  Louis,  MO,  USA),  proteins  were  probed  with  primary
antibodies against rabbit anti-IL10 (Abcam, Cambridge, UK), rabbit anti-NT3
(Abcam, Cambridge,  UK),  and rabbit  anti-β actin (CST, Danvers, MA).  The
proteins  were  detected  by  chemiluminescence (Clarity  Substrate,  Thermo
Fisher,  Waltham,  MA).  Quantification  was  performed  with  Image  J  (NIH,
Bethesda, MD).
Immunohistochemistry and quantitative analysis nerve regeneration
and myelination
Spinal  cords  were  extracted  12  weeks  after  SCI  and  flash  frozen  in
isopentane. For immunofluorescence, spinal cord segments were embedded
in  Tissue Tek O.C.T.  Compound (Sakura  Finetek,  Torrance,  CA,  USA)  with
30%  sucrose.  Cords  were  cryo-sectioned  transversely  into  12-μm-thick
sections.  Antibodies  against  the  following  antigens  were  used  for
immunofluorescence:  F4/80  (Abcam,  Cambridge,  UK),  Arginase  1  (Arg1,
Santa Cruz Biotech,  Dallas,  TX,  USA),   neurofilament 200 (NF-200,  Sigma
Aldrich), myelin basic protein (MBP, Santa Cruz Biotech, Dallas, TX, USA), and
Protein-zero myelin protein (P0, Aves Labs, Tigard, OR, USA). Red fluorescent
protein (RFP) was imaged at 488 nm without added antibodies. Tissues were
imaged  on  an  Axio  Observer  Z1  (Zeiss,  Oberkochen,  Germany)  using  a
10x/0.45 or 20x/0.75 M27 apochromatic objective and an ORCA-Flash 4.0 V2
Digital  CMOS  camera  (C11440-22CU,  Hamamatsu  Photonics,  Hamamatsu
City, Shizuoka, Japan).
For  quantification  of  macrophage  phenotypes,  nine  12  μm  thick
transverse tissues were randomly selected from each animal (N=24, 6 per
condition). All immunopositive cell events were counterstained with Hoechst
33342 to indicate cell nuclei. F4/80+ cells and F4/80+/arginase1+ (Arg1+) were
quantified  to  determine  pro-inflammatory  macrophages  and  non-
inflammatory macrophages respectively. Immunopositive cells were counted
within the bridge area by 2 blinded researchers independently. Co-staining
for  multiple  markers  was  assessed  by  evaluating  overlap  of  different
channels in Image J (NIH, Bethesda, MD, USA).
To assess the numbers of regenerated and myelinated axons within the
PLG  bridge  area,  NF-200  was  used  to  identify  axons,  NF-200+/MBP+  to
determine  the  number  of  myelinated  axons,  and  NF-200+/MBP+/P0+  to
determine the amount of myelin derived from infiltrating Schwann cells20.
Twenty-four  tissues  distributed  between  conditions  were  counted  by  2
blinded counters to calibrate software for automated counting as previously
described2,  22, 23, 26.  Briefly, images were imported into MATLAB (Mathworks,
Natick, MA, USA) and the area of the tissue section corresponding to PLG
bridge was outlined. A Hessian matrix was created by convolution filtering
using  second  derivative  of  the  Gaussian  function  in  the  x,  y,  and  xy
directions.  Following  filtering,  positive  NF-200  events  were  identified  by
intensity thresholding, single pixel events were removed, and the number of
continuous  objects  were  identified  to  ensure  high  branching  axons  are
counted as a single object. For calibration, the software will output a matrix
of predicted axon counts based on filtering parameters inputted by the user.
These values are directly compared to manual counts for the twenty-four
tissues  used  for  calibrating  the  software.  The  appropriate  filter  size  and
threshold  sensitivity  are  selected  based  on  the  lowest  mean  percentage
error  between the  manual  and automated counts.  For  these studies,  the
mean percentage error was 3%. Once calibration was complete, nine tissues
per animal (N=24, 6 per condition) were quantified. To obtain axon densities,
total NF-200 counts were divided by the area of the PLG bridge. MBP and P0
events  were  identified  similarly  as  described  above.  NF200  objects
containing pixel locations overlapping with positive MBP or P0 staining were
counted and compared to total NF200 counts to determine percentages of
axons populations.
Behavioral analysis
The ladder beam walking task was used to evaluate locomoter recovery
over a period of 12 weeks post-SCI as previously described for all conditions
(N=48, 12 per condition)  27.  Briefly, animals were trained to walk across a
ladder beam of 50 rungs into an enclosure over the course of 2 weeks before
injury. Baseline scores were determined to separate animals in equal groups
prior to SCI. The mice were tested at 2, 4, 8, and 12 weeks. Observations and
ladder beam scoring were performed by two blinded observers for 3 trials
per animal. Animals were scored by average left forepaw full placements on
the ladder beam during the task. 
Thermal hyperalgesia 
Cold  sensitivity  was  assessed  by  acetone  evaporative  cooling  over  a
period of  12 weeks post-SCI as previously described  28.   Through a mesh
floor, 5 applications of acetone were applied to the bottom of the left and
right  forepaw.  Each  application  was  separated  by  at  least  5  minutes.
Individual responses were scored based on lifting, licking, or shaking of the
forepaw that continued past the initial  application.  Scores were averaged
over  the  ten  applications  between  left  and  right  forepaws  to  yield  a
percentage of positive responses. 
Statistical analysis
For  multiple  comparisons,  statistical  significance  between  groups  was
determined  by  two-way  ANOVA  with  Tukey’s  post-hoc.  For  single
comparisons, the statistical significance between pairs was determined by
unpaired t-test. All statistics test significance using an α value of 0.05. For all
graphs: a, b, c denotes p<0.05 compared to Blank control, d and e denotes
p<0.05 compared NT-3 condition, and f denotes p<0.05 compared to IL-10
condition.  Error  bars  represent  standard  error  in  all  figures.  Prism  7
(GraphPad  Software,  La  Jolla,  CA,  USA)  software  was  used  for  all  data
analysis.
Data Availability
The datasets generated during and/or analyzed during the current study
are available from the corresponding author on reasonable request.
Results
Bi-cistronic vectors conserve IL-10 and NT-3 production in vivo
We  initially  assessed  protein  levels  following  expression  from  the
lentivirus with a single construct and also the bi-cistronic construct (Error:
Reference  source  not  found).  Bridges  were  implanted  into  mice  and
explanted at 2 weeks post injury (wpi). This time point was selected based
on  previous  studies  using  bioluminescence  imaging  that  demonstrates
robust  transgene  expression  19.  The  proteins  used  in  these  studies  are
human which enabled differentiation of the IL-10 and NT-3 produced by our
constructs  from  the  mouse  proteins.  No  significant  difference  in  protein
expression  was  observed  between  single  constructs  or  the  bi-cistronic
construct.  Furthermore,  for  the  bi-cistronic  construct,  no  significant
difference in protein expression was observed between the first gene, IL-10,
and the second gene, NT-3. 
IL-10 delivery increases anti-inflammatory macrophages
We next investigated the macrophages populations in the bridge at 12
wpi  (Error:  Reference source not  found),  as  this  population  could  be
influenced by the cytokine and neurotrophin expression. This analysis was
performed at  12 wpi  to analyze the chronic  infiltration and phenotype of
macrophages.  We observed most  of  the  macrophages at  the injury  were
localized to the bridge and not the surrounding tissue (Error: Reference
source  not  foundA).  The  macrophages  in  the  bridge  were  evenly
distributed and were observed in all conditions at similar densities (Error:
Reference  source  not  foundF).  For  these  studies,  pro-regenerative
macrophages were assessed by co-localization of F4/80 and arginase (Arg)
(Error: Reference source not foundG). A significant 3-fold increase in the
density  of  regenerative  macrophages  was  observed  for  conditions  with
expression of IL-10 compared to the Blank and NT-3 conditions. Differences
among  these  conditions  were  also  significant  for  the  percentage  of  pro-
regenerative macrophages. Notably 31% and 26% of F4/80+  macrophages
were regenerative for IL-10 and IL-10+NT-3 conditions respectively, a 2-fold
increase over Blank and NT-3 conditions (12% and 14%) (Error: Reference
source not foundH). 
Delivery of IL-10+NT3 enhances axonal growth into bridges
The  extent  of  axonal  elongation  into  the  bridge  was  subsequently
analyzed, which reflects the impact of expressing the factors on the capacity
of the environment to promote regeneration (Error: Reference source not
found). Axons were observed throughout the bridge in all conditions. Axons
in treatment groups appeared longer and more diffuse while axons in the
control condition appeared bundled and shorter in length (Error: Reference
source  not  foundA-D).  NT-3  and  IL-10  delivery  did  not  significantly
increase axonal density compared to control. However, combined delivery of
IL-10+NT-3 produced a significant increase of axonal density compared to all
other conditions (Error: Reference source not foundE).
IL-10+NT-3 delivery promotes myelination of regenerating axons
Myelination  of  axons  is  necessary  for  signal  propagation  in  the  spinal
cord, and myelinated axons (NF200+/MBP+) were observed throughout the
bridges  for  all  conditions  (Error:  Reference  source  not  found).
Significantly more myelinated axons were observed in the IL-10 condition
compared to the Blank bridge. IL-10+NT-3 delivery resulted in significantly
more  myelinated  axons  compared  to  Blank  and  NT-3  conditions  (Error:
Reference source not foundE). No significant difference was observed in
the percentage of  myelinated axons across  the conditions,  with levels  at
approximately 27% of total axons (Error: Reference source not foundF). 
Myelinated axons were sub-divided into oligodendrocyte-derived myelin
(NF200+/MBP+/P0-) and  Schwann  cell-derived  myelin  (NF200+/MBP+/P0+)
(Error:  Reference  source  not  found)  to  determine  their  relative
contribution  to  total  myelination.  A  significant  2-fold  increase  in
oligodendrocyte-derived  myelin  density  was  observed  for  IL-10+NT-3
compared  to  Blank  and  NT-3  conditions  (Error:  Reference  source  not
foundE). IL-10 delivery resulted in a significant increase of oligodendrocyte
myelin compared to control. However, no significant difference in density of
Schwann  cell-derived  myelin  was  observed  across  all  conditions  (Error:
Reference source not foundF). 
IL-10+NT-3 improves forelimb locomotor recovery 
The ladder beam task was used to evaluate functional motor recovery of
the left forelimb to determine if the observed regeneration correlated with an
increase in function (Error: Reference source not foundA). A significant
functional improvement was observed for all conditions compared to Blank.
Furthermore, a significant increase in functional recovery was obtained with
IL-10+NT-3 delivery compared to all other conditions at 12 wpi. Interestingly,
a greater prolonged improvement over time was observed for IL-10+NT-3
condition compared to other conditions.  IL-10 and NT-3 delivery were similar
in functional recovery, however co-delivery produced a significant additive
effect in locomotor recovery. 
We also assessed cold hypersensitivity using the acetone test to identify
any  potential  negative  effects  that  may  be  associated  with  combined
delivery  (Error:  Reference  source  not  foundB).  IL-10  delivery  alone
reduced cold hypersensitivity compared to all other conditions. NT-3 delivery
alone  exacerbated  hypersensitivity  compared  to  all  conditions.   The
combined  expression  of  IL-10+NT-3  led  to  increased  hypersensitivity
compared to IL-10 alone,  yet decreased hypersensitivity  relative to Blank
and NT-3 conditions.
As  a  final  analysis,  we  investigated  the  association  of  tissue recovery
characteristics with forelimb locomotor function recovery (Error: Reference
source not found). The values for axon density (Error: Reference source
not  foundA),  myelinated  axon  density  (Error:  Reference  source  not
foundB),  oligodendrocyte-derived  myelinated  axon  density  (Error:
Reference  source  not  foundC),  and  Schwann  cell-derived  myelinated
axon density (Error: Reference source not foundD) were plotted against
the  ladder  beam score  for  each  animal.  The  oligodendrocyte  myelinated
axon  density  was  positively  correlated  with  functional  recovery  (r=0.59,
p<0.01).  This  relationship  also  segments  animals  by  condition  along  the
interpolated  linear  fit  line.  This  relationship  was  the  only  significant
connection between tissue characteristics and functional recovery. 
Discussion
The central nervous system has the innate capacity to repair itself post-
SCI,  yet the spinal  cord environment lacks sufficient factors that promote
regeneration and has an abundance of factors that inhibit regeneration9. We
have  developed  multichannel  PLG bridges  that  can  promote  nerve
regeneration by both acting as a physical guide and serve as a platform for
gene  therapy  vector  delivery.  The  bridges  are  acellular  at  implantation,
indicating that any cells, extracellular matrix, or proteins present at the time
of  extraction  must  have originated  from the host  tissue.  Similarly,  axons
observed  inside  the  implant  are  either  regenerating  injured  axons  or
sprouting  of  new  axons  from  spared  or  contralateral  tissue.  This  bridge
provides a defined space for histological analysis, analysis of cell populations
at  and near  the lesion  site,  and treatment outcomes.  The bridge has an
architecture  that  supports  regeneration  by  combining  micro-porosity  for
cellular  infiltration  with  channels  that  direct  axonal  elongation  along  the
major axis of the cord. These bridges can also be seeded with recombinant
lentiviral  particles  containing  genes  of  interest  for  subsequent  cellular
transduction.  Unlike  other  viral  vectors,  lentivirus  does  not  influence  the
phenotype  of  progenitors29 or  cause  significant  inflammation30.  Lentiviral
vectors  physical  properties  are  also  independent  of  the  gene of  interest,
which enables delivery of multiple vectors encoding distinct inductive factors
without modification to the base biomaterial. Poly-cistronic lentiviral vectors
can deliver multiple genes by the inclusion of self-cleaving 2A peptide sites
between genes. This technology is useful and beneficial to target multiple
barriers to spinal cord regeneration by inducing the expression of multiple
proteins simultaneously.  The genes being used in this study were chosen
because each addresses a distinct aspect of the inhibitory microenvironment
around the injury site. NT-3 enhances axon elongation and neuroprotection
of  regenerating  and  spared  axons19,  31,  32.  IL-10  is  largely  responsible  for
dampening  and  resolving  the  immune  response  toward  restoring
homeostasis  13,  33,  34.  This research builds upon the success of the multiple
channel  poly(lactide-co-glycolide)  (PLG)  bridges  by  delivering  2  distinct
transgenes alone and in combination. The goal of this investigation was to
activate growth promoting cues while attenuating growth inhibitory cues to
observe additive effects on spinal cord regeneration. 
Similar  macrophage  infiltration  into  bridges  was  observed  across
experimental conditions delivering, yet transgene expression could alter the
macrophage phenotype.  Lentiviral  constructs  are  minimally  immunogenic,
yet the transgene can influence the microenvironment30,  35-37.  Macrophage
phenotypes exist  on a  spectrum of  inflammatory to regenerative and we
have  previously  shown  that  Arg1+ macrophages  have  a  regenerative
phenotype  in  SCI  11,  23.  For  the  purposes  of  this  paper,  regenerative
macrophages  were  assessed  by  co-localization  of  F4/80+ and  Arg1+.  The
early  phase  of  the  regenerative  response  following  SCI  relies  on  pro-
inflammatory macrophages, which participate in recruitment of immune cells
and clearance of cell debris. Subsequently, these macrophages shift to a pro-
regenerative  phenotype  to  coordinate  cell  differentiation  and  tissue
reconstruction. Dysregulation of this transition from pro-inflammatory to pro-
regenerative hampers regenerative success and tissue recovery. In the CNS,
microglia  and  macrophages  express  several  neurotrophins  and  their
receptors,  allowing  them to  act  both  as  sources  and  targets  creating  a
feedback loop that can modulate proliferation and morphology of axons  38.
Neurotrophins impact immune cell function in varying ways. BDNF stimulates
microglial  proliferation  while  NT-3  can  stimulate  phagocytic  activity  of
microglial cells in vitro and upregulation of nitric oxide production 39-41. NGF
can also act directly on microglial cells by promoting chemotactic migratory
activity, potentially contributing to recruitment of additional immune cells at
injury  sites42.  Neurotrophins,  including  NT-3,  have  been  suggested  as
modulating  monocyte  chemotaxis  without  altering  their  production  of
inflammatory cytokines 43. NGF can act directly on microglia  and shift them
toward a neuroprotective phenotype 42. In these studies, we did not observe
an anti-inflammatory effect of NT-3 on macrophage activity. IL-10 delivery
alone produced  ~31% of  regenerative  macrophages,  but  when combined
with  NT-3,  this  percentage  decreased  to  26%.  This  difference  was  not
significant.  IL-10  has  been  extensively  revered  as  an  anti-inflammatory
cytokine capable of shifting the phenotype of macrophages22, 44-48 and these
studies support the previous findings.
A trend of increased axons for NT-3 and IL-10 compared to blank, yet the
combination of IL-10+NT-3 produced an additive effect for axonal outgrowth.
Axonal outgrowth can be impacted by delivery of NT-3 and IL-10 individually
19, 22, 23, however in our studies, these individual factors did not substantially
impact axon density relative to control, which likely results from the relative
types of  neurons in the C5 lateral  hemisection model  compared with the
previous reports. A larger number of propriospinal neurons are present in the
cervical spinal cord than the thoracic spinal cord, with intrinsic differences
also reported for  growth factors,  cell  surface receptors,  apoptosis,  axonal
regeneration,  neuroprotection,  and cell  survival  49-52.   Our  results  indicate
that the combined expression of IL-10 and NT-3 does significantly enhance
axon density at the cervical hemisection. This synergy is likely related to the
sparing of axons by IL-10 and the neurotrophic effects of NT-3. Effectively,
the  greater  survival  of  neurons  by IL-10 leads to  an increase number  of
axons that can regenerate into the injury. 
An increase in  myelinated axons for  IL-10+NT-3 delivery,  notably  with
oligodendrocyte myelinated axons was observed. Oligodendrocyte myelin is
necessary to support saltatory conduction and prevent axon degeneration 53.
Oligodendrocyte proliferation is not altered by NT-3, NT-3 exposure in vitro
lead to significantly more MBP production by oligodendrocytes through an
unknown posttranscriptional mechanism 54, 55. Some evidence suggests that
NT-3  weakly  induces  the  maturation  of  neural  precursor  cells  into
myelinating  oligodendrocytes  56,  yet  other  reports  have  shown  NT-3
promotes  quiescence  or  even  Schwann  cell  differentiation  of  neural
precursor  cells20,  57-59.  These  differences  could  indicate  concentration
dependent effects or vary with surrounding interactions with other factors.
We  observed  that  IL-10  delivery  had  significantly  more  oligodendrocyte-
derived  myelin  relative  to  control.  IL-10  polarization  of  immune  cells
enhances the ability  of  neural  precursor  cells to promote oligodendrocyte
differentiation and supports mature oligodendrocyte survival by promoting
an anti-inflammatory  environment  rather  than acting  on neural  precursor
cells directly  60. Our results are consistent with this observation that IL-10
promoted the survival of myelinating oligodendrocytes, which can synergize
with the expression of NT-3 to potentiate their myelin production to ensheath
more axons. This mechanism has been suggested in other work combining
IL-10 and NT-3 delivery for treatment of multiple sclerosis  61.   We did not
observe an increase in oligodendrocyte myelination for NT-3 delivery alone,
possibly due to lack of surviving oligodendrocytes and weak effects of NT-3
on their proliferation and differentiation 56. 
Oligodendrocyte myelination significantly correlated increased functional
recovery. We assessed locomotor recovery on the ladder beam walking task
over  the  course  of  12  weeks.  All  treatment  conditions  had  significant
improvements  in  functional  recovery  relative  to  control,  yet  IL-10+NT-3
delivery  was  substantially  improved  relative  to  all  other  conditions.  A
significant  correlation  between  ladder  beam  score  and  oligodendrocyte
myelinated  axon  density  was  observed,  suggesting  that  oligodendrocyte
myelination of axons is a limiting step in functional recovery for our model.
The functional benefit of oligodendrocyte myelin versus Schwann cell myelin
have been debated in the literature, yet any conclusion remains nebulous.
Some  reports  suggest  oligodendrocyte  myelin  is  not  necessary  in
spontaneous functional recovery 62; however, prolonged recovery as seen in
these studies may require oligodendrocyte myelin for restoration of function.
The  various  injury  models  may  differentially  impact  oligodendrocytes  as
oligodendrocyte have been seen as less important in contusion models  62.
Our hemisection model severs and removes existing axons and cells in the
lesion, while contusion models retain the damaged tissue. 
A decrease in hypersensitivity was observed with IL-10 delivery while NT-
3  delivery  alone  increased  hypersensitivity.  IL-10  has  been  shown  to
ameliorate neuropathic pain but the role played by neurotrophins and NT-3
has  been  nebulous  63.  NT-3  can  be  involved  in  a  long-term  change  of
neuronal excitability64. NT-3 also promotes an extensive growth of lesioned
axons  in  the  dorsal  columns  which  contain  mostly  sensory  projections.
Furthermore, the effects of NT-3 on neuropathic pain may be concentration
or receptor dependent65-67. Our results suggest NT-3 exacerbates neuropathic
pain. However, there exists a tradeoff of positive and negative effects. We
observed  the  highest  degree  of  functional  recovery  when  combining  IL-
10+NT-3, yet we also observed increased neuropathic pain compared to IL-
10 alone. 
Conclusion
Overall  our results show that the combination of  IL-10+NT-3 enhanced
axonal  growth  and  oligodendrocyte  myelinated  axon  density,  and  with
increased locomotor functional recovery compared to IL-10 or NT-3 alone.
Hypersensitivity  with  the  combination  was  increased  compared  to  IL-10
alone  yet  decreased  relative  to  NT-3  alone.  Furthermore,  a  positive
correlation was observed between oligodendrocyte myelinated axon density
and functional recovery, suggesting oligodendrocyte myelination as a target
to  further  improve  functional  recovery.  Poly-cistronic  vectors  provide  a
mechanism for expression of  multiple transgenes that can simultaneously
address multiple aspects that limit regeneration. Multichannel PLG bridges
provide a growth supportive substrate and a platform to deliver bioactive
agents as well as a defined space to investigate the SCI microenvironment
and to assess the biological impact of treatments. 
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